| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,647,700 | 1,699,700 | 1,695,900 | 1,695,100 | | Cost of Revenue | 1,169,200 | 1,203,900 | 1,180,100 | 1,191,000 | | | Gross Profit | 478,500 | 495,800 | 515,800 | 504,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 249,600 | 254,400 | 248,000 | 263,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 228,900 | 241,400 | 267,800 | 241,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,300) | (6,300) | (3,800) | 8,200 | | Earnings Before Interest And Taxes | 221,300 | 235,100 | 264,000 | 246,300 | | Interest Expense | 30,700 | 30,700 | 28,800 | 27,200 | | Income Before Tax | 190,600 | 204,400 | 235,200 | 219,100 | | Income Tax Expense | 45,700 | 54,800 | 61,900 | 50,500 | | Minority Interest | 7,700 | (7,700) |
-
| (3,000) | | | | Net Income From Continuing Ops | 152,600 | 141,900 | 173,300 | 168,600 | | | Non-recurring Events | | Discontinued Operations | 3,300 | 31,200 | 500 | 100 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 155,900 | 173,100 | 173,800 | 168,700 | | Preferred Stock And Other Adjustments | (10,500) | 4,000 | (4,000) |
-
| | | Net Income Applicable To Common Shares | $145,400 | $177,100 | $169,800 | $168,700 |
|
0.01% Nasdaq 
0.22%
Income Statement
